Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 47 for “"MPNST"”.

  1. Dissecting Tumor Evolution and Immune Composition in PRC2 Loss (H3K27me3 Loss) vs Retained MPNST

    Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas that arise sporadically or in the setting of neurofibromatosis type 1 (NF1). Although benign plexiform neurofibromas (PNs) are common in NF1, only a subset undergo malignant transformation, and the molecular events that …

    wustl Repository record for Dissecting Tumor Evolution and Immune Composition in PRC2 Loss (H3K27me3 Loss) vs Retained MPNST (opens in a new tab)

  2. Protective role of PACAP and VIP on Malignant Peripheral Nerve Sheath Tumor (MPNST) cells

    Malignant peripheral nerve sheath tumors (MPNSTs) are often associated with poor prognosis and patient outcome. These tumors grow under conditions of metabolic stress caused by insufficient nutrients or oxygen. In our previous study we have identified PACAP, VIP and their receptors in rat MPNST …

    catania Repository record for Protective role of PACAP and VIP on Malignant Peripheral Nerve Sheath Tumor (MPNST) cells (opens in a new tab)

  3. Induction And Regulation Of Autophagy By Novel Prenylation Inhibitors In Sts-26t Malignant Peripheral Nerve Sheath Tumor (mpnst) Cells

    … STS-26T malignant peripheral nerve sheath tumor (MPNST) cells. We found that GGTI-2Z/lovastatin inhibit proliferation, cause cell cycle arrest in the G1 phase and induce autophagy in STS-26T MPNST cells. FTI-1/lovastatin not only inhibit proliferation and cause cell cycle arrest, but also induce …

    wayne-thes Repository record for Induction And Regulation Of Autophagy By Novel Prenylation Inhibitors In Sts-26t Malignant Peripheral Nerve Sheath Tumor (mpnst) Cells (opens in a new tab)

  4. IDENTIFY THE EFFECTS OF CSF1R MODULATION IN NF1-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMOR CELL SURVIVAL AND RESPONSIVENESS TO SHP2 INHIBITION

    Malignant peripheral nerve sheath tumors (MPNST) are a leading cause of mortality in patients with neurofibromatosis type 1 (NF1). MPNST are rare and aggressive soft tissue sarcoma of the peripheral nervous system. MPNST are difficult to treat because they are relatively insensitive to conventional …

    jhu Repository record for IDENTIFY THE EFFECTS OF CSF1R MODULATION IN NF1-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMOR CELL SURVIVAL AND RESPONSIVENESS TO SHP2 INHIBITION (opens in a new tab) Embargoed until 2030-05-01

  5. Poly (Adp) Ribose Polymerase Inhibitors For The Treatment of Malignant Peripheral Nerve Sheath Tumor

    Malignant peripheral nerve sheath tumor (MPNST) is a rare subtype of soft tissue sarcoma. Surgical excision has remained the standard of care for this highly aggressive malignancy for over a decade. Conventional chemotherapy and radiotherapy have shown limited efficacy in MPNST; therefore, it is …

    uthsc Repository record for Poly (Adp) Ribose Polymerase Inhibitors For The Treatment of Malignant Peripheral Nerve Sheath Tumor (opens in a new tab)

  6. Genes differentially expressed in Neurofibromatosis type 1 benign and malignant peripheral nerve sheath tumours

    … malignant peripheral nerve sheath tumours (MPNST). MPNST that usually arise from pre-existing pNFs are highly aggressive malignancies and have a dismal prognosis. To identify genes involved in NF1-tumourigenesis we performed gene expression analysis applying cDNA array technology. 26 …

    fu-berlin Repository record for Genes differentially expressed in Neurofibromatosis type 1 benign and malignant peripheral nerve sheath tumours (opens in a new tab)

  7. Novel Small Molecule Induces Apoptosis in Malignant Peripheral Nerve Sheath Tumors of Neurofibromatosis Type I

    … into malignant peripheral nerve sheath tumors (MPNSTs), a main cause of mortality. Currently, surgery is the primary course of treatment for MPNST, but with the limitation that these tumors are highly invasive. Radiotherapy is another treatment option, but is undesirable because it can induce …

    utswmed Repository record for Novel Small Molecule Induces Apoptosis in Malignant Peripheral Nerve Sheath Tumors of Neurofibromatosis Type I (opens in a new tab)

  8. Modification of RHAMM and TPX2 optimizes Aurora kinase A (AURKA) inhibition in malignant peripheral nerve sheath tumours

    Malignant peripheral nerve sheath tumours (MPNST) are rare, hereditary cancers associated with neurofibromatosis type I. MPNSTs lack effective treatments as they often resist chemotherapies and have high rates of disease recurrence. Published analysis of copy number variation identified hemizygous …

    ubc Repository record for Modification of RHAMM and TPX2 optimizes Aurora kinase A (AURKA) inhibition in malignant peripheral nerve sheath tumours (opens in a new tab) Download PDF for Modification of RHAMM and TPX2 optimizes Aurora kinase A (AURKA) inhibition in malignant peripheral nerve sheath tumours (opens in a new tab)

  9. Molecular Characterization of the Spectrum of Peripheral Nerve Sheath Tumors

    Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive sarcoma, and the most lethal form of cancer in the context of neurofibromatosis type 1. The current standard of care includes surgery plus radiation, with no effective chemo or targeted therapeutic options. Here we examined the …

    toronto-retro Repository record for Molecular Characterization of the Spectrum of Peripheral Nerve Sheath Tumors (opens in a new tab)

  10. Modulation der Biologie maligner peripherer Nervenscheidentumorzellen durch Midkine

    Maligne periphere Nervenscheidentumoren (MPNST) sind aggressive Weichteiltumoren, die sporadisch auftreten können. Häufiger sind sie jedoch mit der Neurofibromatose vom Typ 1 (NF1) assoziiert. Die Prognose von MPNST ist unverändert ungünstig, da die Tumoren zumeist chirurgisch nicht resezierbar …

    fu-berlin Repository record for Modulation der Biologie maligner peripherer Nervenscheidentumorzellen durch Midkine (opens in a new tab)

  11. ZNF423 Defines a Targetable Transcriptional Dependency in NF1-Associated Malignant Peripheral Nerve Sheath Tumors

    Malignant peripheral nerve sheath tumors (MPNST) are aggressive sarcomas with limited effective systemic therapies and represent the leading cause of mortality in individuals with neurofibromatosis type 1 (NF1). While the genetic alterations underlying malignant transformation of benign plexiform …

    iupui Repository record for ZNF423 Defines a Targetable Transcriptional Dependency in NF1-Associated Malignant Peripheral Nerve Sheath Tumors (opens in a new tab)

  12. Targeting Histone Deacetylases (Hdac) For The Treatment of Soft Tissue Sarcoma

    … in malignant peripheral nerve sheath tumor (MPNST), a subtype of highly aggressive, therapeutically resistant, and commonly fatal malignancies that occur in patients with neurofibromatosis type-1 (NF1) or sporadically. The therapeutic efficacy of HDACi was investigated in a panel of …

    uthsc Repository record for Targeting Histone Deacetylases (Hdac) For The Treatment of Soft Tissue Sarcoma (opens in a new tab)

  13. Investigating the role of SWI/SNF in malignant peripheral nerve sheath tumours

    Malignant peripheral nerve sheath tumours (MPNST) are rare and aggressive soft tissue sarcomas that are typically therapy resistant. Mutations of genes involved in the polycomb repressive complex 2 (PRC2), an important modulator of transcriptional repression, occur in up to 75% of MPNST cases. In …

    qu-belfast Repository record for Investigating the role of SWI/SNF in malignant peripheral nerve sheath tumours (opens in a new tab) Embargoed until 2028-07-31

  14. Identification and characterization of the secretome in neurofibromatosis type 1 tumors

    … into malignant peripheral nerve sheath tumors (MPNST). The incidence of MPNST is associated with the individual PNF burden of NF1 patients. At present, only a fraction of NF1 patients with PNF can be identified by physical examination. Although advanced imaging technology monitors internal PNF …

    fu-berlin Repository record for Identification and characterization of the secretome in neurofibromatosis type 1 tumors (opens in a new tab)

  15. Targeting the intersection of molecular signaling pathways and tumor immunobiology in NF1-associated malignant peripheral nerve sheath tumors

    Malignant peripheral nerve sheath tumors (MPNST) are a leading cause of death among patients with neurofibromatosis type 1 (NF1). MPNST are aggressive soft tissue sarcomas with a tendency for recurrence and distant metastases. They are difficult to treat because of their relative insensitivity to …

    jhu Repository record for Targeting the intersection of molecular signaling pathways and tumor immunobiology in NF1-associated malignant peripheral nerve sheath tumors (opens in a new tab)

  16. Mechanisms of AT101 [(-)-Gossypol] Induced Cytotoxicity in Malignant Peripheral Nerve Sheath Tumors

    Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive Schwann cell-derived sarcomas and are the leading cause of mortality in patients with neurofibromatosis type 1 (NF1). Current treatment modalities have been largely ineffective resulting in a high rate of MPNST recurrence and poor …

    uab Repository record for Mechanisms of AT101 [(-)-Gossypol] Induced Cytotoxicity in Malignant Peripheral Nerve Sheath Tumors (opens in a new tab)

  17. Identification of transcriptional mechanisms downstream of nf1 gene defeciency in malignant peripheral nerve sheath tumors

    Malignant peripheral nerve sheath tumor (MPNST) is a type of soft tissue sarcoma that occurs in carriers of mutations in the neurofibromatosis type I gene (Nf1) as well as sporadically. Plexiform neurofibromas in NF1 patients have a significant risk of developing into MPNSTs leading to increased …

    wayne-thes Repository record for Identification of transcriptional mechanisms downstream of nf1 gene defeciency in malignant peripheral nerve sheath tumors (opens in a new tab)

  18. The role of IFITM1 in malignant progression of neurofibromas in NF1

    … to malignant peripheral nerve sheath tumors (MPNSTs) remained unclear, genetic and epigenetic changes involved in MPNST pathogenesis. Here I found that interferon-induced transmembrane protein 1 (IFITM1) was downregulated in MPNST tissues compared to that in PN tissues from NF1 patients by …

    ajou Repository record for The role of IFITM1 in malignant progression of neurofibromas in NF1 (opens in a new tab) Embargoed until 9999-12-31

  19. EVALUATING RATIONAL COMBINATIONS WITH GLUTAMINE ANTAGONISTS IN NF1/RAS-ACTIVE SARCOMA MODELS

    Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft-tissue sarcomas that arise in patients with neurofibromatosis type 1 (NF1) and remain relatively insensitive to conventional systemic therapies. Loss of the tumor suppressor neurofibromin leads to constitutive RAS signaling and …

    jhu Repository record for EVALUATING RATIONAL COMBINATIONS WITH GLUTAMINE ANTAGONISTS IN NF1/RAS-ACTIVE SARCOMA MODELS (opens in a new tab)

  20. Role of Ras Proteins in Malignant Peripheral Nerve Sheath Tumors

    Malignant peripheral nerve sheath tumors (MPNSTs) arising in patients with neurofibromatosis type I (NF1) are null for the tumor suppressor neurofibromin, a negative regulator of signaling from both classic Ras (H-Ras, N-Ras and K-Ras) and R-Ras (R-Ras, R-Ras2/TC21, M-Ras/R-Ras3) subfamily members. …

    uab Repository record for Role of Ras Proteins in Malignant Peripheral Nerve Sheath Tumors (opens in a new tab)

Page 1 of 3